Domů › Rakovina vaječníků › Maryland › Baltimore
Klinické studie Rakovina vaječníků v Baltimore, MD
22 studií pro Rakovina vaječníků hledá účastníky v lokalitách v Baltimore a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Probíhá náborFáze 2
- University of Maryland/Greenebaum Cancer Center, Baltimore
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 2
- Johns Hopkins University, Baltimore
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
Probíhá náborFáze 3
- Research Site, Baltimore
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Probíhá náborFáze 2
- University of Maryland, Baltimore /ID# 275308, Baltimore
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Probíhá náborFáze 3
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital Of Baltimore, Baltimore
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Probíhá náborFáze 1
- United Theranostics, Glen Burnie · Vzdálenost 9 mi
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Probíhá náborFáze 2
- Greater Baltimore Medical Center, Baltimore
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Probíhá náborFáze 1/2
- Research Site, Baltimore
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
Probíhá náborFáze 3
- Greater Baltimore Medical Center, Towson · Vzdálenost 8 mi
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Probíhá náborFáze 2/3
- University of Maryland/Greenebaum Cancer Center, Baltimore
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Probíhá náborFáze 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Probíhá náborFáze 2
- The John Hopkins Hospital, Baltimore
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
Probíhá náborFáze 3
- University of Maryland, Baltimore
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Probíhá náborFáze 3
- Greater Baltimore Medical Center, Towson · Vzdálenost 8 mi
EXoPERT EMERALD Clinical Study
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- John Hopkins University, Baltimore
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
Probíhá náborFáze 1
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Probíhá náborFáze 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Probíhá náborFáze 2
- SCRI - Maryland Oncology Hematology, P.A., Annapolis · Vzdálenost 22 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · Vzdálenost 8 mi
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
Probíhá náborFáze 2
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Probíhá náborObservační studie
- Johns Hopkins University School of Medicine, Baltimore
- Anne Arundel Health System, Annapolis · Vzdálenost 22 mi
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Probíhá náborFáze 1/2
- Johns Hopkins, Baltimore
Studie Rakovina vaječníků v jiných městech
- Houston, TX89 studií
- New York City, NY69 studií
- Boston, MA61 studií
- Los Angeles, CA50 studií
- Nashville, TN49 studií
- Arlington, VA46 studií
- Philadelphia, PA44 studií
- Columbus, OH39 studií
- St. Louis, MO38 studií
- Chicago, IL36 studií
- San Antonio, TX31 studií
- Cleveland, OH30 studií
Další studie v Baltimore
- Nemalobuněčný plicní karcinom60 studií
- Rakovina prsu47 studií
- Rakovina prostaty43 studií
- Rakovina plic40 studií
- Rakovina (všechny typy)37 studií
- Kolorektální karcinom31 studií
- Rakovina slinivky břišní31 studií
- Metastatický karcinom28 studií
- Obesity25 studií
- Srdeční selhání24 studií
- Rakovina močového měchýře24 studií
- Mrtvice22 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.